Core Points - After nearly six months of investigation, Jiaying Pharmaceutical received a total fine of 4.9 million yuan for information disclosure violations, along with warnings and regulatory actions from the Guangdong Securities Regulatory Bureau and the Shenzhen Stock Exchange [2][5][9] Group 1: Administrative Penalties - The Guangdong Securities Regulatory Bureau issued an administrative penalty decision, imposing a fine of 1.5 million yuan on Jiaying Pharmaceutical, and additional fines on key executives: 1.6 million yuan on Chairman Li Neng, 1 million yuan on General Manager You Yongping, and 800,000 yuan on former CFO Shi Junping, totaling 4.9 million yuan [5][8] - Warnings and regulatory letters were issued to Jiaying Pharmaceutical and its executives, including Li Neng, You Yongping, Shi Junping, and former board secretary Xiao Qiaoxia [5][9] Group 2: Violations and Findings - The investigation revealed that Li Neng, as the actual controller of Hunan Yaojun Pharmaceutical Co., engaged in improper fund transfers between Jiaying Pharmaceutical and its related party, resulting in a total of approximately 220 million yuan in transactions, which accounted for 28.83% of Jiaying Pharmaceutical's latest audited net assets [7][8] - Jiaying Pharmaceutical failed to disclose related party transactions in a timely manner, including transactions with Gonghe Pharmaceutical, which involved approximately 8.76 million yuan, representing 1.15% of the company's latest audited net assets [7][8] Group 3: Additional Regulatory Actions - The Shenzhen Stock Exchange issued a public reprimand against Jiaying Pharmaceutical and its executives, citing violations related to non-operating fund transfers and improper financial assistance [12][13] - Jiaying Pharmaceutical provided a total of 65 million yuan in financial assistance to three non-related companies, with a maximum daily balance of 40 million yuan, which accounted for 5.24% of the company's latest audited net assets [12]

11月21日晚，多家上市公司及相关责任人因涉嫌信息披露违法违规等问题，披露收到监管部门立案告知 书、行政处罚事先告知书或行政处罚决定书的相关公告。 在市场人士看来，集中披露上述公告彰显了监管部门强化执法震慑，对信息披露违法违规行为的"零容 忍"态度，有助于持续增强投资者信任和信心。 豪尔赛表示，公司将积极配合调查工作，目前各项经营活动正常有序开展，本次立案不会对公司经营和 管理造成重大影响。 因信息披露违法违规 嘉应制药收行政处罚决定书 嘉应制药（002198）11月21日晚公告称，公司于当日收到广东证监局下发的《行政处罚决定书》。 涉嫌信披违法违规 两家公司被证监会立案 聚石化学11月21日晚公告称，公司于当日收到证监会下发的《立案告知书》，因公司涉嫌信息披露违法 违规，证监会决定对公司立案。 聚石化学表示，目前公司各项经营活动和业务均正常开展。立案调查期间，公司将积极配合证监会的相 关工作，并严格按照相关法律法规和监管要求及时履行信息披露义务。 豪尔赛（002963）11月21日晚公告称，公司近日收到证监会下发的《立案告知书》，因涉嫌信息披露违 法违规，证监会对公司进行立案。 智动力实控人及时任高管 收行 ...

Core Viewpoint - Haosai (002963.SZ) has received a notice of investigation from the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to a formal investigation under relevant Chinese laws [1] Financial Performance - In the first three quarters of 2025, Haosai reported a net profit attributable to shareholders of -26.31 million yuan, a year-on-year decline of 523.96% [2] - The net profit attributable to shareholders after excluding non-recurring gains and losses was -31.63 million yuan, a year-on-year decline of 317.90% [2] - From 2021 to 2024, the company's operating revenues were 788 million yuan, 407 million yuan, 538 million yuan, and 459 million yuan respectively [2] - The net profits attributable to shareholders during the same period were 13 million yuan, -156 million yuan, 18 million yuan, and -179 million yuan respectively [2] - The net cash flow from operating activities for the years 2021 to 2024 was 66 million yuan, -165 million yuan, 139 million yuan, and -99 million yuan respectively [2] Initial Public Offering (IPO) Details - Haosai was listed on the Shenzhen Stock Exchange on October 28, 2019, with a public offering of 37.59 million shares at a price of 23.66 yuan per share [1] - The company raised a total of 889 million yuan, with a net amount of 801 million yuan after deducting issuance costs [1] - The funds raised were allocated for various projects, including 650 million yuan for operational funds for engineering projects and 55.52 million yuan for LED lighting R&D [1]

Core Viewpoint - Ju Shi Chemical has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following significant adjustments to its financial performance forecasts for 2024 [1][2]. Group 1: Regulatory Actions - On November 21, 2025, Ju Shi Chemical received a notice of investigation from the CSRC due to suspected violations of information disclosure laws [1]. - The investigation is based on the company's financial disclosures and adjustments made in its 2024 annual performance report [1]. Group 2: Financial Performance Adjustments - In the announcement on April 29, 2025, Ju Shi Chemical revised its 2024 financial forecasts, reporting a corrected operating profit of -241 million yuan, a decrease of 76.99% [1]. - The total profit was adjusted to -242 million yuan, reflecting a decline of 75.52%, while the net profit attributable to shareholders was revised to -236 million yuan, down 64.6% [1]. - The basic earnings per share were adjusted to -1.95 yuan, a reduction of 0.77 yuan or 65.25% from previous estimates [1]. Group 3: Reasons for Financial Adjustments - The discrepancies in the financial data were primarily attributed to underperformance of Guangdong Guanzhen Technology Co., Ltd., which Ju Shi Chemical acquired in 2021, leading to a provision for impairment losses of 43.62 million yuan [2]. - Additional adjustments included a write-off of fixed assets amounting to 11.63 million yuan, impairment losses on intangible assets of 21 million yuan, and impairment losses related to leased fixed assets totaling 21.75 million yuan [2]. Group 4: Market Impact - As of November 21, 2025, Ju Shi Chemical's stock closed at 22.21 yuan per share, with a market capitalization of 2.69 billion yuan [3].

Group 1 - Two A-share companies, Jushi Chemical and Haosai, have been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [1][5] - Jushi Chemical received a notice from the CSRC on November 21, 2025, regarding the investigation, and the company will cooperate with the regulatory body during this period [1][3] - Haosai also announced its investigation by the CSRC and stated that its business operations remain normal and orderly [5][7] Group 2 - Jushi Chemical reported a revenue of 987 million yuan for Q3 2025, a year-on-year decrease of 0.81%, with a net profit attributable to shareholders of 2.89 million yuan [3][4] - Haosai achieved a revenue of 1.07 billion yuan for Q3 2025, reflecting a year-on-year increase of 31.34%, and a net profit attributable to shareholders of 740.11 thousand yuan, a significant increase of 599.72% [7][8] - Jushi Chemical's main products include modified plastic particles, automotive profiles, optical materials, and flame retardants, while Haosai focuses on smart technology services in various sectors [3][7]

2家上市公司，公告被证监会立案。 11月21日晚，聚石化学（688669）公告称，公司于2025年11月21日收到中国证监会下发的《立案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对 公司立案。 聚石化学称，目前公司各项经营活动和业务均正常开展，将积极配合中国证监会的相关工作，并及时履行信息披露义务。 同日，豪尔赛（002963）公告，公司于近日收到中国证监会下发的《立案告知书》，因涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和 国行政处罚法》等法律法规，中国证监会对公司进行立案。 值得注意的是，豪尔赛曾于2025年7月29日公告，公司实际控制人之一戴宝林为支持戴聪棋作为上市公司控股股东暨实际控制人行使股东权利，更好地行使公司经 营管理及重大事项决策权，与戴聪棋签署了《关于豪尔赛科技集团股份有限公司之表决权委托协议》，将持有的公司3512.84万股股份（占公司总股本的 23.36%）对应的全部表决权、召集权、提名和提案权、参会权、监督建议权以及除收益权和股份转让权等财产性权利之外的其他权利独家委托给戴聪棋行使。本 次表决权委托后，公司控股股东、实际控制人变更为戴聪棋和刘清梅；戴宝林、 ...

嘉应制药公告，公司及相关责任人收到中国证券监督管理委员会广东监管局下发的《行政处罚决定 书》。因公司信息披露违法违规，被处以警告并罚款150万元；董事长李能罚款160万元；总经理游永平 罚款100万元；时任财务总监史俊平罚款80万元。公司表示，该处罚不会对公司生产经营产生重大影 响。 ...

Core Viewpoint - 聚石化学 and 豪尔赛 are both under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact their operations and investor confidence [1][5]. Company Overview - 聚石化学 specializes in the research, production, and sales of new chemical materials, with products including modified plastic particles, automotive profiles, optical materials, and flame retardants, among others [3]. - 豪尔赛 focuses on technology innovation, developing smart lighting, smart cultural tourism, and smart urban areas, along with a digital twin integration network platform [7]. Financial Performance - 聚石化学 reported a revenue of 986.58 million yuan for Q3 2025, a decrease of 0.81% year-on-year, with a net profit of 2.89 million yuan [4]. - 豪尔赛 achieved a revenue of 106.94 million yuan for Q3 2025, an increase of 31.34% year-on-year, with a net profit of 740.11 thousand yuan, reflecting a significant growth of 599.72% [8].

Core Viewpoint - The stock of Kexin Information has plummeted due to an investigation by the China Securities Regulatory Commission (CSRC) for suspected information disclosure violations related to a contract fraud case involving over 100 million yuan [2][3]. Group 1: Company Financials and Performance - Kexin Information's stock fell to 14.41 yuan per share, with a total market value of 3.475 billion yuan, and there were significant sell orders queued at the market [2]. - The company initially projected a net profit loss of no more than 99 million yuan for 2023, but this was later revised to a loss of up to 181 million yuan, nearly doubling the initial estimate [5]. - The final audited net profit for 2023 was confirmed as a loss of 166 million yuan, indicating significant financial distress [5]. Group 2: Legal and Regulatory Issues - The CSRC issued a notice of investigation due to Kexin Information's involvement in a contract fraud case, which has led to a correction of accounting errors in their financial reports [2][4]. - The company reported that it is cooperating with the CSRC during the investigation and will adhere to disclosure obligations [2]. - The case involves Kexin Information's contracts with Dayou Technology, which are linked to a larger fraud scheme, and both companies have reported the matter to law enforcement [3][4]. Group 3: Operational Impact - Despite the ongoing investigation, Kexin Information stated that its business operations are continuing normally [2]. - The company has faced challenges in collecting outstanding payments from Dayou Technology due to disputes over contract amounts with their client, Sichuan Comprehensive Energy Service Co., Ltd. [3]. - The likelihood of recovering the remaining payments is considered low, as some key suspects may have fled the country [4].

Core Viewpoint - Kexin Information (300730.SZ) has hit a trading limit down, reaching a new low of 14.41 yuan since early August, with a total market value of less than 3.5 billion yuan due to regulatory scrutiny from the China Securities Regulatory Commission (CSRC) [1] Group 1 - Kexin Information received a "Notice of Investigation" from the CSRC on November 17, 2025, for suspected violations of information disclosure laws [1] - The company did not disclose specific reasons for the investigation in its announcement, stating that all business activities are currently operating normally [1] - Kexin Information previously reported experiencing over 100 million yuan in contract fraud [1]